Download PDF

Other users also viewed these articles

P-61 CLINICAL APPLICATION OF NAFLD FIBROSIS SCORE AND HEPAMET FIBROSIS SCORE IN CORONARY ARTERY DISEASE AND MASLD: A CROSS-SECTIONAL STUDY IN WESTERN MEXICAN POPULATION José Antonio Velarde Chávez; Francisco Alejandro Félix Téllez; Jorge Alberto Martínez Ortiz; Neisser Morales Victorino; Claudia Ximena Vásquez Veloza; Diana Karen Tapia Calderón; José Roberto Barrientos Avalos; José Antonio Velarde Ruiz Velasco;
Ann Hepatol. 2024;29 Supl 3:
PREDICTIVE FACTORS OF RESPONSE TO URSODEOXYCHOLIC ACID TREATMENT IN MEXICAN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS Fátima Higuera de la Tijera; Graciela Elia Castro Narro; Ana Cano Contreras; José Luis Pérez Hernández; Jorge Emilio Lira Vera; José Antonio Velarde Ruiz Velasco;
Ann Hepatol. 2025;30 Supl 2:
P-37 EXPERIENCE IN MEXICO WITH DIRECT ACTING ANTIVIRALS AS A TREATMENT FOR HEPATITIS C J.L. Pérez Hernández; Aldo Torre Delgadillo; Graciela Castro Narro; Eira Cerda Reyes; Mayra Virginia Ramos Gómez; Leonardo Juárez Chávezx; Margarita Dehesa Violante; Linda Muñoz Espinosa; Laura Cisneros Garza; Ignacio Aiza Haddad; José Antonio Velarde Ruiz Velasco; Raul Contreras Omaña; Nancy García Casarreal; Armando Carmona Castañea José; María de Fátima Higuera de la Tijera;
Ann Hepatol. 2021;24 Supl 1: